Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Biotechnology

Editor-in-Chief

ISSN (Print): 1389-2010
ISSN (Online): 1873-4316

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Diagnostic Accuracy and Validity of Serological and Molecular Tests for Hepatitis B and C

Author(s): Moein Zangiabadian, Amir Zamani, Mohammad Javad Nasiri, Elham Behzadi and Abbas Ali Imani Fooladi*

Volume 23, Issue 6, 2022

Published on: 19 July, 2021

Page: [803 - 817] Pages: 15

DOI: 10.2174/1389201022666210719162802

Price: $65

Abstract

Introduction: Hepatitis B and C viruses are one of the leading causes of health problems in the world and early diagnosis and treatment of them are very important. Thereby, this study aimed to evaluate the validity and reliability of usable diagnostic tests for the detection of hepatitis B and C viruses in the clinical setting and to compare them with each other.

Materials and Methods: In this review article, we have searched major online databases, including PubMed and EMBASE. 42 retrieved articles were published between January 2000 and January 2020, which are summarized in this review.

Results: Immunoassay approaches are general techniques for the identification of pathogenic agents, among which ELISA is the gold standard for the detection of HBsAg. While serological techniques are not conclusive, molecular assays are really important because of the high sensitivity to detect chronic hepatitis B without HBeAg, in which viral loads are very low. Biosensors have more elevated selectivity and sensitivity and faster responses compared to other methods.

Conclusion: This study suggests that all of the molecular, serological, and biotechnological assays have advantages and disadvantages for diagnosing hepatitis B and C viruses which are dependent on the condition, so we should choose one of them in regards to the time, cost, and laboratory equipment along with the clinical symptoms.

Keywords: Hepatitis B virus, hepatitis C virus, diagnostic tests, serological assays, rapid Point-of-care test, molecular methods.

« Previous Next »
[1]
WHO, World Hepatitis Day. More must be done to stop this silent killer. 2013.
[2]
March, C.; Manclús, J.J.; Jiménez, Y.; Arnau, A.; Montoya, A. A piezoelectric immunosensor for the determination of pesticide residues and metabolites in fruit juices. Talanta, 2009, 78(3), 827-833.
[http://dx.doi.org/10.1016/j.talanta.2008.12.058] [PMID: 19269436]
[3]
Lok, A.S.; McMahon, B.J. Chronic hepatitis B. Hepatology, 2001, 34(6), 1225-1241.
[http://dx.doi.org/10.1053/jhep.2001.29401] [PMID: 11732013]
[4]
Beasley, R.P. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer, 1988, 61(10), 1942-1956.
[http://dx.doi.org/10.1002/1097-0142(19880515)61:10<1942::AIDCNCR2820611003>3.0.CO;2-J] [PMID: 2834034]
[5]
Tyas, A.A.; Raeni, S.F.; Sakti, S.P.; Sabarudin, A. Recent advances of hepatitis b detection towards paper-based analytical devices. ScientificWorldJournal, 2021, 2021, 6643573-6643573.
[http://dx.doi.org/10.1155/2021/6643573] [PMID: 33727897]
[6]
World Health, O. Hepatitis B vaccines. 2009, 84, 405-420.
[7]
Shepard, C.W.; Simard, E.P.; Finelli, L.; Fiore, A.E.; Bell, B.P. Hepatitis b virus infection: Epidemiology and vaccination. Epidemiol. Rev., 2006, 28, 112-125.
[http://dx.doi.org/10.1093/epirev/mxj009] [PMID: 16754644]
[8]
Gasiorowicz, M.; Hurie, M.; Russell, A.; Hoxie, N.; Vergeront, J. Epidemiologic trends in infection, mortality, and transplants related to hepatitis C in Wisconsin. WMJ, 2006, 105(1), 34-39.
[PMID: 16676489]
[9]
WHO Global hepatitis report., https://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/
[10]
Doan, T.Q. Hepatitis c in developing countries in Southeast Asia.Hepatitis C in developing countries; Kamal, S.M., Ed.; Academic Press, 2018, pp. 97-104.
[http://dx.doi.org/10.1016/B978-0-12-803233-6.00009-6]
[11]
Ringelhan, M.; McKeating, J.A.; Protzer, U. Viral hepatitis and liver cancer. Philos. Trans. R. Soc. Lond. B Biol. Sci., 2017, 372(1732), 20160274.
[http://dx.doi.org/10.1098/rstb.2016.0274] [PMID: 28893941]
[12]
Martin, N.K.; Vickerman, P.; Dore, G.J.; Hickman, M. The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM): The use of direct-acting antivirals as treatment for prevention. Curr. Opin. HIV AIDS, 2015, 10(5), 374-380.
[http://dx.doi.org/10.1097/COH.0000000000000179] [PMID: 26248124]
[13]
Midgard, H.; Weir, A.; Palmateer, N.; Lo Re, V., III; Pineda, J.A.; Macías, J.; Dalgard, O. HCV epidemiology in high-risk groups and the risk of reinfection. J. Hepatol., 2016, 65(1)(Suppl.), S33-S45.
[http://dx.doi.org/10.1016/j.jhep.2016.07.012] [PMID: 27641987]
[14]
Ayoub, H.H.; Abu-Raddad, L.J. Impact of treatment on hepatitis C virus transmission and incidence in Egypt: A case for treatment as prevention. J. Viral Hepat., 2017, 24(6), 486-495.
[http://dx.doi.org/10.1111/jvh.12671] [PMID: 28039923]
[15]
Fraser, H.; Martin, N.K.; Brummer-Korvenkontio, H.; Carrieri, P.; Dalgard, O.; Dillon, J.; Goldberg, D.; Hutchinson, S.; Jauffret-Roustide, M.; Kåberg, M.; Matser, A.A.; Matičič, M.; Midgard, H.; Mravcik, V.; Øvrehus, A.; Prins, M.; Reimer, J.; Robaeys, G.; Schulte, B.; van Santen, D.K.; Zimmermann, R.; Vickerman, P.; Hickman, M. Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe. J. Hepatol., 2018, 68(3), 402-411.
[http://dx.doi.org/10.1016/j.jhep.2017.10.010] [PMID: 29080808]
[16]
Butt, A.S.; Sharif, F.; Abid, S. Impact of direct acting antivirals on occurrence and recurrence of hepatocellular carcinoma: Biologically plausible or an epiphenomenon? World J. Hepatol., 2018, 10(2), 267-276.
[http://dx.doi.org/10.4254/wjh.v10.i2.267] [PMID: 29527262]
[17]
Singer, A.W.; Reddy, K.R.; Telep, L.E.; Osinusi, A.O.; Brainard, D.M.; Buti, M.; Chokkalingam, A.P. Direct-acting antiviral treatment for hepatitis C virus infection and risk of incident liver cancer: A retrospective cohort study. Aliment. Pharmacol. Ther., 2018, 47(9), 1278-1287.
[http://dx.doi.org/10.1111/apt.14593] [PMID: 29516535]
[18]
Easterbrook, P.J.; Roberts, T.; Sands, A.; Peeling, R. Diagnosis of viral hepatitis. Curr. Opin. HIV AIDS, 2017, 12(3), 302-314.
[http://dx.doi.org/10.1097/COH.0000000000000370] [PMID: 28306597]
[19]
Jackson, K.; Locarnini, S.; Gish, R. Diagnostics of hepatitis B virus: standard of care and investigational. Clin. Liver Dis. (Hoboken), 2018, 12(1), 5-11.
[http://dx.doi.org/10.1002/cld.729] [PMID: 30988902]
[20]
Amini, A.; Varsaneux, O.; Kelly, H.; Tang, W.; Chen, W.; Boeras, D.I.; Falconer, J.; Tucker, J.D.; Chou, R.; Ishizaki, A.; Easterbrook, P.; Peeling, R.W. Diagnostic accuracy of tests to detect hepatitis B surface antigen: A systematic review of the literature and meta-analysis. BMC Infect. Dis., 2017, 17(1)(Suppl. 1), 698.
[http://dx.doi.org/10.1186/s12879-017-2772-3] [PMID: 29143619]
[21]
Blumberg, B.S.; Sutnick, A.I.; London, W.T.; Millman, I. Australia antigen and hepatitis. N. Engl. J. Med., 1970, 283(7), 349-354.
[http://dx.doi.org/10.1056/NEJM197008132830707] [PMID: 4246769]
[22]
Engvall, E.; Perlmann, P. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry, 1971, 8(9), 871-874.
[http://dx.doi.org/10.1016/0019-2791(71)90454-X] [PMID: 5135623]
[23]
Wolters, G.; Kuijpers, L.; Kacaki, J.; Schuurs, A. Solid-phase enzyme-immunoassay for detection of hepatitis B surface antigen. J. Clin. Pathol., 1976, 29(10), 873-879.
[http://dx.doi.org/10.1136/jcp.29.10.873] [PMID: 789402]
[24]
Dane, D.S.; Cameron, C.H.; Briggs, M. Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet, 1970, 1(7649), 695-698.
[http://dx.doi.org/10.1016/S0140-6736(70)90926-8] [PMID: 4190997]
[25]
Datta, S.; Chatterjee, S.; Veer, V. Recent advances in molecular diagnostics of hepatitis B virus. World J. Gastroenterol., 2014, 20(40), 14615-14625.
[http://dx.doi.org/10.3748/wjg.v20.i40.14615] [PMID: 25356025]
[26]
Chen, C.J.; Yang, H.I.; Su, J.; Jen, C.L.; You, S.L.; Lu, S.N.; Huang, G.T.; Iloeje, U.H. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA, 2006, 295(1), 65-73.
[http://dx.doi.org/10.1001/jama.295.1.65] [PMID: 16391218]
[27]
Chevaliez, S.; Pawlotsky, J.M. Diagnosis and management of chronic viral hepatitis: Antigens, antibodies and viral genomes. Best Pract. Res. Clin. Gastroenterol., 2008, 22(6), 1031-1048.
[http://dx.doi.org/10.1016/j.bpg.2008.11.004] [PMID: 19187865]
[28]
O’Connor, L.; Glynn, B. Recent advances in the development of nucleic acid diagnostics. Expert Rev. Med. Devices, 2010, 7(4), 529-539.
[http://dx.doi.org/10.1586/erd.10.22] [PMID: 20583889]
[29]
Craw, P.; Balachandran, W. Isothermal nucleic acid amplification technologies for point-of-care diagnostics: A critical review. Lab Chip, 2012, 12(14), 2469-2486.
[http://dx.doi.org/10.1039/c2lc40100b] [PMID: 22592150]
[30]
Ziegler, C.; Göpel, W. Biosensor development. Curr. Opin. Chem. Biol., 1998, 2(5), 585-591.
[http://dx.doi.org/10.1016/S1367-5931(98)80087-2] [PMID: 9818183]
[31]
Gill, P.; Ghaemi, A. Nucleic acid isothermal amplification technologies: A review. Nucleosides Nucleotides Nucleic Acids, 2008, 27(3), 224-243.
[http://dx.doi.org/10.1080/15257770701845204] [PMID: 18260008]
[32]
Shivkumar, S.; Peeling, R.; Jafari, Y.; Joseph, L.; Pant Pai, N. Accuracy of rapid and point-of-care screening tests for hepatitis C: A systematic review and meta-analysis. Ann. Intern. Med., 2012, 157(8), 558-566.
[http://dx.doi.org/10.7326/0003-4819-157-8-201210160-00006] [PMID: 23070489]
[33]
Mokhtarzadeh, A.; Eivazzadeh-Keihan, R.; Pashazadeh, P.; Hejazi, M.; Gharaatifar, N.; Hasanzadeh, M.; Baradaran, B.; de la Guardia, M. Nanomaterial-based biosensors for detection of pathogenic virus. Trends Analyt. Chem., 2017, 97, 445-457.
[http://dx.doi.org/10.1016/j.trac.2017.10.005] [PMID: 32287543]
[34]
Chen, C.C.; Lai, Z.L.; Wang, G.J.; Wu, C.Y. Polymerase chain reaction-free detection of hepatitis B virus DNA using a nanostructured impedance biosensor. Biosens. Bioelectron., 2016, 77, 603-608.
[http://dx.doi.org/10.1016/j.bios.2015.10.028] [PMID: 26479905]
[35]
Lee, S.; Kim, Y.S.; Jo, M.; Jin, M.; Lee, D.K.; Kim, S. Chip-based detection of hepatitis C virus using RNA aptamers that specifically bind to HCV core antigen. Biochem. Biophys. Res. Commun., 2007, 358(1), 47-52.
[http://dx.doi.org/10.1016/j.bbrc.2007.04.057] [PMID: 17475212]
[36]
Firdaus, R.; Saha, K.; Biswas, A.; Sadhukhan, P.C. Current molecular methods for the detection of hepatitis C virus in high risk group population: A systematic review. World J. Virol., 2015, 4(1), 25-32.
[http://dx.doi.org/10.5501/wjv.v4.i1.25] [PMID: 25674515]
[37]
Heiat, M.; Ranjbar, R.; Alavian, S.M. Classical and modern approaches used for viral hepatitis diagnosis. Hepat. Mon., 2014, 14(4), e17632-e17632.
[http://dx.doi.org/10.5812/hepatmon.17632] [PMID: 24829586]
[38]
Liu, Y.P.; Yao, C.Y. Rapid and quantitative detection of hepatitis B virus. World J. Gastroenterol., 2015, 21(42), 11954-11963.
[http://dx.doi.org/10.3748/wjg.v21.i42.11954] [PMID: 26576084]
[39]
Villar, L.M.; Cruz, H.M.; Barbosa, J.R.; Bezerra, C.S.; Portilho, M.M. Scalioni, Lde.P. Update on hepatitis B and C virus diagnosis. World J. Virol., 2015, 4(4), 323-342.
[http://dx.doi.org/10.5501/wjv.v4.i4.323] [PMID: 26568915]
[40]
Njai, H.F.; Shimakawa, Y.; Sanneh, B.; Ferguson, L.; Ndow, G.; Mendy, M.; Sow, A.; Lo, G.; Toure-Kane, C.; Tanaka, J.; Taal, M.; D’alessandro, U.; Njie, R.; Thursz, M.; Lemoine, M. Validation of rapid point-of-care (POC) tests for detection of hepatitis B surface antigen in field and laboratory settings in the Gambia, Western Africa. J. Clin. Microbiol., 2015, 53(4), 1156-1163.
[http://dx.doi.org/10.1128/JCM.02980-14] [PMID: 25631805]
[41]
Grange, R.D.; Thompson, J.P.; Lambert, D.G. Radioimmunoassay, enzyme and non-enzyme-based immunoassays. Br. J. Anaesth., 2014, 112(2), 213-216.
[http://dx.doi.org/10.1093/bja/aet293] [PMID: 24431350]
[42]
Bottero, J.; Boyd, A.; Gozlan, J.; Lemoine, M.; Carrat, F.; Collignon, A.; Boo, N.; Dhotte, P.; Varsat, B.; Muller, G.; Cha, O.; Picard, O.; Nau, J.; Campa, P.; Silbermann, B.; Bary, M.; Girard, P.M.; Lacombe, K. Performance of rapid tests for detection of HBsAg and anti-HBsAb in a large cohort, France. J. Hepatol., 2013, 58(3), 473-478.
[http://dx.doi.org/10.1016/j.jhep.2012.11.016] [PMID: 23183527]
[43]
Gholami Parizad, E.; Khosravi, A.; Gholami Parizad, E.; Sayehmiri, K.; Ranjbar, R. Detection of HBV DNA in cerumen and sera of hbsag negative patients with chronic hepatitis B infection. Iran. Red Crescent Med. J., 2012, 14(3), 186-187.
[PMID: 22737579]
[44]
Shibayama, T.; Masuda, G.; Ajisawa, A.; Hiruma, K.; Tsuda, F.; Nishizawa, T.; Takahashi, M.; Okamoto, H. Characterization of seven genotypes (A to E, G and H) of hepatitis B virus recovered from Japanese patients infected with human immunodeficiency virus type 1. J. Med. Virol., 2005, 76(1), 24-32.
[http://dx.doi.org/10.1002/jmv.20319] [PMID: 15779062]
[45]
Echevarría, J.M.; Avellón, A. Hepatitis B virus genetic diversity. J. Med. Virol., 2006, 78(Suppl. 1), S36-S42.
[http://dx.doi.org/10.1002/jmv.20605] [PMID: 16622876]
[46]
Liu, C.; Chang, L.; Jia, T.; Guo, F.; Zhang, L.; Ji, H.; Zhao, J.; Wang, L. Real-time PCR assays for hepatitis B virus DNA quantification may require two different targets. Virol. J., 2017, 14(1), 94.
[http://dx.doi.org/10.1186/s12985-017-0759-8] [PMID: 28494793]
[47]
Datta, S.; Banerjee, A.; Chandra, P.K.; Chakravarty, R. Selecting a genetic region for molecular analysis of hepatitis B virus transmission. J. Clin. Microbiol., 2007, 45(2), 687-688.
[http://dx.doi.org/10.1128/JCM.02046-06] [PMID: 17277176]
[48]
Datta, S.; Banerjee, A.; Chandra, P.K.; Biswas, A.; Panigrahi, R.; Mahapatra, P.K.; Panda, C.K.; Chakrabarti, S.; Bhattacharya, S.K.; Chakravarty, R. Analysis of hepatitis B virus X gene phylogeny, genetic variability and its impact on pathogenesis: implications in Eastern Indian HBV carriers. Virology, 2008, 382(2), 190-198.
[http://dx.doi.org/10.1016/j.virol.2008.09.007] [PMID: 18952249]
[49]
Sanders, R.; Huggett, J.F.; Bushell, C.A.; Cowen, S.; Scott, D.J.; Foy, C.A. Evaluation of digital PCR for absolute DNA quantification. Anal. Chem., 2011, 83(17), 6474-6484.
[http://dx.doi.org/10.1021/ac103230c] [PMID: 21446772]
[50]
Cai, Q.; Zhao, Z.; Liu, Y.; Shao, X.; Gao, Z. Comparison of three different HCV genotyping methods: core, NS5B sequence analysis and line probe assay. Int. J. Mol. Med., 2013, 31(2), 347-352.
[http://dx.doi.org/10.3892/ijmm.2012.1209] [PMID: 23241873]
[51]
Kato, N. Genome of human hepatitis C virus (HCV): gene organization, sequence diversity, and variation. Microb. Comp. Genomics, 2000, 5(3), 129-151.
[http://dx.doi.org/10.1089/omi.1.2000.5.129] [PMID: 11252351]
[52]
Moradpour, D.; Penin, F. Hepatitis C virus proteins: from structure to function. Curr. Top. Microbiol. Immunol., 2013, 369, 113-142.
[http://dx.doi.org/10.1007/978-3-642-27340-7_5] [PMID: 23463199]
[53]
Bartenschlager, R.; Cosset, F.L.; Lohmann, V. Hepatitis C virus replication cycle. J. Hepatol., 2010, 53(3), 583-585.
[http://dx.doi.org/10.1016/j.jhep.2010.04.015] [PMID: 20579761]
[54]
Yao, C.Y.; Fu, W.L. Biosensors for hepatitis B virus detection. World J. Gastroenterol., 2014, 20(35), 12485-12492.
[http://dx.doi.org/10.3748/wjg.v20.i35.12485] [PMID: 25253948]
[55]
Tong, D.; Chen, C.; Zhang, J.; Lv, G.; Zheng, X.; Zhang, Z.; Lv, X. Application of Raman spectroscopy in the detection of hepatitis B virus infection. Photodiagn. Photodyn. Ther., 2019, 28, 248-252.
[http://dx.doi.org/10.1016/j.pdpdt.2019.08.006] [PMID: 31425766]
[56]
Jin, F.; Li, H.; Xu, D. Enzyme-free fluorescence microarray for determination of hepatitis B virus DNA based on silver nanoparticle aggregates-assisted signal amplification. Anal. Chim. Acta, 2019, 1077, 297-304.
[http://dx.doi.org/10.1016/j.aca.2019.05.066] [PMID: 31307722]
[57]
Tang, D.; Yuan, R.; Chai, Y.; Zhong, X.; Liu, Y.; Dai, J. Electrochemical detection of hepatitis B surface antigen using colloidal gold nanoparticles modified by a sol-gel network interface. Clin. Biochem., 2006, 39(3), 309-314.
[http://dx.doi.org/10.1016/j.clinbiochem.2005.12.003] [PMID: 16503333]

Rights & Permissions Print Cite
Article Metrics
18
1
© 2024 Bentham Science Publishers | Privacy Policy